As of 2026-04-21, the EV/EBITDA ratio of Takeda Pharmaceutical Co Ltd (4502.T) is 10.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4502.T's latest enterprise value is 13,068,651.00 mil JPY. 4502.T's TTM EBITDA according to its financial statements is 1,227,540.00 mil JPY. Dividing these 2 quantities gives us the above 4502.T EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 11.8x | 10.1x |
| Forward P/E multiples | 11.9x - 13.8x | 12.6x |
| Fair Price | 3,361.77 - 6,434.30 | 4,466.06 |
| Upside | -39.7% - 15.4% | -19.9% |
| Date | EV/EBITDA |
| 2026-04-20 | 10.65 |
| 2026-04-17 | 10.66 |
| 2026-04-16 | 10.74 |
| 2026-04-15 | 10.75 |
| 2026-04-14 | 10.68 |
| 2026-04-13 | 10.73 |
| 2026-04-10 | 10.85 |
| 2026-04-09 | 10.97 |
| 2026-04-08 | 10.92 |
| 2026-04-07 | 10.94 |
| 2026-04-06 | 10.88 |
| 2026-04-03 | 10.94 |
| 2026-04-02 | 11.05 |
| 2026-04-01 | 11.05 |
| 2026-03-31 | 10.76 |
| 2026-03-30 | 10.83 |
| 2026-03-27 | 10.99 |
| 2026-03-26 | 10.92 |
| 2026-03-25 | 10.96 |
| 2026-03-24 | 10.76 |
| 2026-03-23 | 10.65 |
| 2026-03-19 | 10.90 |
| 2026-03-18 | 11.03 |
| 2026-03-17 | 10.96 |
| 2026-03-16 | 10.86 |
| 2026-03-13 | 10.77 |
| 2026-03-12 | 10.76 |
| 2026-03-11 | 10.88 |
| 2026-03-10 | 10.83 |
| 2026-03-09 | 10.70 |
| 2026-03-06 | 10.79 |
| 2026-03-05 | 10.72 |
| 2026-03-04 | 10.69 |
| 2026-03-03 | 10.84 |
| 2026-03-02 | 10.93 |
| 2026-02-27 | 10.96 |
| 2026-02-26 | 10.85 |
| 2026-02-25 | 10.94 |
| 2026-02-24 | 10.96 |
| 2026-02-20 | 10.92 |
| 2026-02-19 | 10.96 |
| 2026-02-18 | 10.95 |
| 2026-02-17 | 10.62 |
| 2026-02-16 | 10.59 |
| 2026-02-13 | 10.70 |
| 2026-02-12 | 10.69 |
| 2026-02-10 | 10.65 |
| 2026-02-09 | 10.55 |
| 2026-02-06 | 10.57 |
| 2026-02-05 | 10.67 |